My gut feel is
1. 4DS meets HGST and demonstrates/discusses as per last Ann
2. Further testing / analytics and views on future plan / actions formed.
3. 4DS decides to exercise its right to provide a further technical update to its shareholders. One which could, given the content provide a broader appreciation of the nature and capabilities of the tech to a broader audience including competition of WD (potential buyers of 4DS).
4. 4DS prepares a technical update which (checked by IMEC) correctly represents the analysis of the recent PL and NPL and summarises what could come next
5. WD advises that "we'd prefer you didn't"
6. 4DS says, yeah nah, otherwise our shareholders will riot and BTW we are within our rights to initiate an auction for the tech unless you initiate a formal process with us
7. WD goes, let's discuss the "Technical Update". Hence no need to change its name.
8. 4DS advises ASX it requires suspension. A discussion on "technical updates" ensues.
Works for me.
- Forums
- ASX - By Stock
- 4DS
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-80
-
-
- There are more pages in this discussion • 312 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $255.0K | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 0.090 |
3 | 64842 | 0.088 |
11 | 775652 | 0.087 |
6 | 1026804 | 0.086 |
12 | 1362571 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 297513 | 2 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
0.093 | 181179 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online